Pharmacielo Cash vs Cash And Short Term Investments Analysis

PCLO Stock

CAD 0.09 0.01 13.33%

Pharmacielo financial indicator trend analysis is much more than just breaking down Pharmacielo prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharmacielo is a good investment. Please check the relationship between Pharmacielo Cash and its Cash And Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmacielo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Cash vs Cash And Short Term Investments

Cash vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharmacielo Cash account and Cash And Short Term Investments. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Pharmacielo's Cash and Cash And Short Term Investments is 0.87. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Pharmacielo, assuming nothing else is changed. The correlation between historical values of Pharmacielo's Cash and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Pharmacielo are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Cash i.e., Pharmacielo's Cash and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Cash

Cash refers to the most liquid asset of Pharmacielo, which is listed under current asset account on Pharmacielo balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Pharmacielo customers. The amounts must be unrestricted with restricted cash listed in a different Pharmacielo account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Pharmacielo balance sheet. This account contains Pharmacielo investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Pharmacielo fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Pharmacielo's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharmacielo current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmacielo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

At this time, Pharmacielo's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to climb to about 85.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	20.9M	12.3M	11.6M	18.1M
Cost Of Revenue	6.3M	4.5M	2.9M	3.5M

Total Operating Expenses Cost Of Revenue

Pharmacielo fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Net Receivables	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Debt	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Net Invested Capital	Net Working Capital	Inventory	Other Current Assets	Capital Stock	Short Long Term Debt Total	Property Plant And Equipment Net
Total Assets		0.36	0.48	0.76	0.21	-0.71	0.69	0.68	0.76	-0.16	0.59	0.89	0.79	0.76	-0.09	-0.15	0.87	0.75	0.53	0.96	0.2	0.85	-0.86	0.79	0.38	-0.18
Other Current Liab	0.36		0.77	-0.26	0.09	-0.86	0.55	-0.37	-0.01	-0.26	0.86	-0.05	0.75	0.59	0.81	-0.63	-0.05	0.81	-0.01	0.43	-0.63	0.63	-0.72	0.79	0.89	-0.88
Total Current Liabilities	0.48	0.77		-0.17	0.17	-0.86	0.69	-0.2	0.04	-0.29	0.93	0.09	0.73	0.67	0.75	-0.85	0.11	0.77	0.17	0.51	-0.75	0.61	-0.76	0.78	0.76	-0.78
Total Stockholder Equity	0.76	-0.26	-0.17		0.12	-0.09	0.2	0.98	0.81	0.06	-0.08	0.96	0.28	0.31	-0.7	0.39	0.92	0.19	0.41	0.68	0.76	0.48	-0.35	0.24	-0.24	0.43
Net Tangible Assets	0.21	0.09	0.17	0.12		-0.22	0.28	0.04	0.54	0.85	0.16	0.18	0.17	0.58	-0.03	-0.22	0.38	0.25	0.36	0.43	0.08	0.4	-0.34	0.28	0.07	-0.11
Retained Earnings	-0.71	-0.86	-0.86	-0.09	-0.22		-0.82	0.02	-0.35	0.25	-0.97	-0.33	-0.95	-0.86	-0.61	0.57	-0.35	-0.98	-0.34	-0.75	0.46	-0.84	0.96	-0.98	-0.89	0.77
Accounts Payable	0.69	0.55	0.69	0.2	0.28	-0.82		0.12	0.38	-0.12	0.82	0.38	0.83	0.86	0.31	-0.27	0.48	0.83	0.79	0.68	-0.29	0.59	-0.83	0.85	0.67	-0.37
Cash	0.68	-0.37	-0.2	0.98	0.04	0.02	0.12		0.7	0.02	-0.16	0.93	0.16	0.19	-0.74	0.38	0.87	0.06	0.37	0.57	0.74	0.35	-0.22	0.11	-0.36	0.52
Net Receivables	0.76	-0.01	0.04	0.81	0.54	-0.35	0.38	0.7		0.33	0.17	0.85	0.48	0.67	-0.43	0.16	0.91	0.46	0.46	0.85	0.58	0.72	-0.6	0.5	0.06	0.09
Other Stockholder Equity	-0.16	-0.26	-0.29	0.06	0.85	0.25	-0.12	0.02	0.33		-0.31	0.0	-0.23	0.17	-0.31	0.17	0.16	-0.19	0.18	0.03	0.32	0.0	0.13	-0.18	-0.27	0.22
Total Liab	0.59	0.86	0.93	-0.08	0.16	-0.97	0.82	-0.16	0.17	-0.31		0.17	0.88	0.78	0.72	-0.68	0.2	0.91	0.32	0.62	-0.63	0.7	-0.88	0.92	0.88	-0.79
Total Current Assets	0.89	-0.05	0.09	0.96	0.18	-0.33	0.38	0.93	0.85	0.0	0.17		0.48	0.5	-0.5	0.17	0.96	0.41	0.44	0.83	0.58	0.66	-0.56	0.46	-0.03	0.21
Common Stock	0.79	0.75	0.73	0.28	0.17	-0.95	0.83	0.16	0.48	-0.23	0.88	0.48		0.88	0.42	-0.33	0.49	0.99	0.41	0.8	-0.27	0.86	-0.95	0.98	0.86	-0.64
Property Plant Equipment	0.76	0.59	0.67	0.31	0.58	-0.86	0.86	0.19	0.67	0.17	0.78	0.5	0.88		0.27	-0.34	0.62	0.91	0.58	0.86	-0.15	0.86	-0.93	0.92	0.69	-0.5
Net Debt	-0.09	0.81	0.75	-0.7	-0.03	-0.61	0.31	-0.74	-0.43	-0.31	0.72	-0.5	0.42	0.27		-0.77	-0.51	0.5	-0.25	-0.02	-0.93	0.23	-0.38	0.47	0.79	-0.92
Other Assets	-0.15	-0.63	-0.85	0.39	-0.22	0.57	-0.27	0.38	0.16	0.17	-0.68	0.17	-0.33	-0.34	-0.77		0.15	-0.42	0.21	-0.24	0.78	-0.39	0.45	-0.45	-0.48	0.74
Cash And Short Term Investments	0.87	-0.05	0.11	0.92	0.38	-0.35	0.48	0.87	0.91	0.16	0.2	0.96	0.49	0.62	-0.51	0.15		0.44	0.58	0.86	0.56	0.66	-0.59	0.49	-0.02	0.23
Common Stock Shares Outstanding	0.75	0.81	0.77	0.19	0.25	-0.98	0.83	0.06	0.46	-0.19	0.91	0.41	0.99	0.91	0.5	-0.42	0.44		0.38	0.79	-0.34	0.87	-0.97	0.99	0.89	-0.7
Short Term Investments	0.53	-0.01	0.17	0.41	0.36	-0.34	0.79	0.37	0.46	0.18	0.32	0.44	0.41	0.58	-0.25	0.21	0.58	0.38		0.48	0.18	0.22	-0.45	0.42	0.12	0.24
Net Invested Capital	0.96	0.43	0.51	0.68	0.43	-0.75	0.68	0.57	0.85	0.03	0.62	0.83	0.8	0.86	-0.02	-0.24	0.86	0.79	0.48		0.16	0.93	-0.91	0.84	0.43	-0.28
Net Working Capital	0.2	-0.63	-0.75	0.76	0.08	0.46	-0.29	0.74	0.58	0.32	-0.63	0.58	-0.27	-0.15	-0.93	0.78	0.56	-0.34	0.18	0.16		-0.02	0.22	-0.31	-0.63	0.75
Inventory	0.85	0.63	0.61	0.48	0.4	-0.84	0.59	0.35	0.72	0.0	0.7	0.66	0.86	0.86	0.23	-0.39	0.66	0.87	0.22	0.93	-0.02		-0.93	0.89	0.63	-0.56
Other Current Assets	-0.86	-0.72	-0.76	-0.35	-0.34	0.96	-0.83	-0.22	-0.6	0.13	-0.88	-0.56	-0.95	-0.93	-0.38	0.45	-0.59	-0.97	-0.45	-0.91	0.22	-0.93		-0.99	-0.75	0.6
Capital Stock	0.79	0.79	0.78	0.24	0.28	-0.98	0.85	0.11	0.5	-0.18	0.92	0.46	0.98	0.92	0.47	-0.45	0.49	0.99	0.42	0.84	-0.31	0.89	-0.99		0.84	-0.67
Short Long Term Debt Total	0.38	0.89	0.76	-0.24	0.07	-0.89	0.67	-0.36	0.06	-0.27	0.88	-0.03	0.86	0.69	0.79	-0.48	-0.02	0.89	0.12	0.43	-0.63	0.63	-0.75	0.84		-0.89
Property Plant And Equipment Net	-0.18	-0.88	-0.78	0.43	-0.11	0.77	-0.37	0.52	0.09	0.22	-0.79	0.21	-0.64	-0.5	-0.92	0.74	0.23	-0.7	0.24	-0.28	0.75	-0.56	0.6	-0.67	-0.89

Click cells to compare fundamentals

Pharmacielo Account Relationship Matchups

Pharmacielo fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	50.2M	44.0M	36.0M	25.1M	22.3M	26.0M
Total Current Liabilities	3.3M	12.1M	8.1M	7.0M	21.4M	22.5M
Total Stockholder Equity	45.5M	26.2M	19.3M	6.4M	(1.7M)	(1.6M)
Net Tangible Assets	63.2M	43.7M	26.1M	19.3M	22.2M	34.0M
Retained Earnings	(97.5M)	(141.3M)	(167.9M)	(182.4M)	(198.7M)	(188.8M)
Accounts Payable	2.9M	11.7M	7.7M	6.1M	7.0M	5.4M
Cash	13.7M	8.9M	5.3M	173.0K	62.2K	59.1K
Net Receivables	1.8M	924.1K	565.2K	670.7K	229.1K	217.7K
Other Stockholder Equity	26.1M	560.0K	2.0M	560K	504K	478.8K
Total Liab	4.7M	17.8M	16.6M	18.7M	24.0M	25.2M
Total Current Assets	19.7M	12.5M	9.2M	4.0M	3.3M	3.2M
Common Stock	116.8M	138.1M	156.3M	161.7M	186.0M	93.1M
Property Plant Equipment	19.5M	28.7M	30.8M	26.1M	30.0M	22.8M
Net Debt	(12.1M)	(4.4M)	3.1M	12.4M	18.2M	19.1M
Non Current Assets Total	30.5M	31.5M	26.8M	21.1M	19.0M	20.2M
Cash And Short Term Investments	13.8M	9.6M	5.6M	326.0K	374.9K	356.1K
Common Stock Shares Outstanding	96.1M	112.5M	145.6M	151.0M	169.1M	106.0M
Short Term Investments	269.8K	106K	750.1K	291K	153K	0.0
Liabilities And Stockholders Equity	50.2M	44.0M	36.0M	25.1M	28.9M	28.5M
Non Current Liabilities Total	1.4M	5.7M	8.6M	11.8M	2.6M	4.7M
Net Invested Capital	45.5M	29.4M	26.5M	18.7M	16.6M	21.5M
Net Working Capital	16.4M	462.0K	1.1M	(2.9M)	(18.1M)	(17.2M)
Inventory	3.6M	1.3M	2.3M	2.1M	2.3M	2.1M
Other Current Assets	426.6K	732.1K	721.3K	889.2K	800.3K	760.3K
Accumulated Other Comprehensive Income	26.1M	28.9M	28.9M	26.5M	30.5M	24.3M
Capital Stock	116.8M	138.1M	156.3M	161.7M	166.0M	135.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pharmacielo Stock Analysis

When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC